CCL22 and Alzheimer disease: In early AD, immune reactivity is skewed toward a Th2-type response; during the acute phase keratinocytes, DCs and dermal fibroblasts produce CCL17 and CCL22, thereby recruiting Th2 cells via CCR4 (6, 40, 41).